Locations:
Search IconSearch
February 2, 2023/Neurosciences/Podcast

A High-Intensity, Home-Based Rehabilitation Model for Stroke (Podcast)

Aim is to match outcomes of inpatient rehab at greater convenience and lower cost

Cleveland Clinic recently launched high-intensity, at-home rehabilitation for patients following stroke. Known as Home Care Plus, the model involves physical, occupational and speech therapy as well as nursing and custodial services.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“The catalyst was to identify some opportunity to help patients get home in their own environment, where most prefer to be anyway, in a way that is cost-effective while still providing rehabilitation and other services needed for recovery after discharge,” says Joshua Johnson, PT, DPT, PhD, Director of Outcome Research in Cleveland Clinic’s Department of Physical Medicine and Rehabilitation.

Dr. Johnson received a five-year grant from the federal Agency for Healthcare Research and Quality to evaluate the Home Care Plus model. In the most recent episode of Cleveland Clinic’s Neuro Pathways podcast, he shares what has been learned about the model’s effectiveness so far and how it might evolve. Dr. Johnson discusses:

  • The inception of an alternative post-acute care model for patients after stroke
  • The design of a retrospective study examining the first patients participating in Home Care Plus
  • Initial results regarding the model’s effectiveness
  • Challenges with high-intensity, home-based rehabilitation, including staffing and multidisciplinary communication
  • Next steps and long-term goals for Home Care Plus

Click the podcast player above to listen to the 21-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: Are there any initial results you’re seeing regarding the effectiveness of this model, or is it too early?

Advertisement

Dr. Johnson: At this point we have done mostly descriptive analyses. In general, however, patients are doing well. These patients are discharged from the hospital at a functional level that would be consistent with having difficulty walking down a hallway, for example. But by the time they are done with this program, which has lasted an average of about 19 days for the entire home care episode, patients are at a point where they not only can walk down a hallway but can start to navigate an outdoor environment a bit better.

What we are eager to do is then compare and contrast those outcomes relative to patients who go to an inpatient rehabilitation facility so that we can understand whether the outcomes are at least as good, within the same general time frame, for these patients going home. Again, we are aiming to give patients an opportunity to heal in their own environment if that is what they’re interested in. And if it is shown that their outcomes are the same at home as in an inpatient rehabilitation facility, then that represents higher-value care. That is really what we’re after.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad